市場調查報告書

細胞株開發的全球市場

Cell Line Development

出版商 Global Industry Analysts, Inc. 商品編碼 938816
出版日期 內容資訊 英文 212 Pages
商品交期: 最快1-2個工作天內
價格
細胞株開發的全球市場 Cell Line Development
出版日期: 2020年07月01日內容資訊: 英文 212 Pages
簡介

全球細胞株開發的市場在新型冠狀病毒感染疾病 (COVID-19)的世界性流行及伴隨而來的經濟不景氣下,預測期間內預計將以14.4%的年複合成長率推移。

調查對象企業範例

  • Abzena PLC
  • American Type Culture Collection (ATCC)
  • Apath LLC
  • Bioceros
  • Catalent, Inc.
  • CELLforCURE
  • Cobra Biologics
  • Corning, Inc.
  • Cyagen US Inc.
  • Cytovance Biologics
  • Epistem Holdings PLC
  • EuBiologics Co., Ltd.
  • GE Healthcare
  • GVK Biosciences Private Limited
  • Hitachi Chemical Advanced Therapeutics Solutions, LLC
  • Lonza Group Ltd.
  • MilliporeSigma
  • NAEJA-RGM Pharmaceuticals, Inc.
  • Paragon Bioservices, Inc.
  • Patheon, Inc.
  • Promocell GmbH
  • Samsung BioLogics
  • Sartorius AG
  • Selexis SA
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec

本報告提供全球細胞株開發的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的變化與預測,各種區分·各地區·各主要國家的詳細分析,競爭環境,主要企業簡介等資訊。

I 簡介·調查手法·調查範圍

II 摘要整理

第1章 市場概要

  • 全球企業佔有率
  • 企業佔有率方案
  • Covid-19的影響·景氣衰退預測

第2章 主要企業

第3章 市場趨勢·成長推進因素

第4章 全球市場的展望

III 市場分析

  • 市場分析:各地區·各主要國家

IV 競爭

  • 企業簡介
目錄
Product Code: MCP10946

Global Cell Line Development Market to Reach US$10.7 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Cell Line Development estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$10.7 Billion by 2027, growing at a CAGR of 12.3% over the analysis period 2020-2027.Equipment, one of the segments analyzed in the report, is projected to grow at a 12.5% CAGR to reach US$4.5 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Media segment is readjusted to a revised 12.8% CAGR for the next 7-year period. This segment currently accounts for a 51.7% share of the global Cell Line Development market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 11.8% CAGR for the Period of 2020-2027

The Cell Line Development market in the U.S. is estimated at US$1.4 Billion in the year 2020. The country currently accounts for a 29.51% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.9 Billion in the year 2027 trailing a CAGR of 11.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.8% and 10.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9% CAGR while Rest of European market (as defined in the study) will reach US$1.9 Billion by the year 2027.

Accessories & Consumables Segment Corners a 6.4% Share in 2020

In the global Accessories & Consumables segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$242 Million in the year 2020 will reach a projected size of US$380.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.We bring years of research experience to this 8th edition of our report. The 212-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abzena PLC
  • American Type Culture Collection (ATCC)
  • Apath LLC
  • Bioceros
  • Catalent, Inc.
  • CELLforCURE
  • Cobra Biologics
  • Corning, Inc.
  • Cyagen US Inc.
  • Cytovance Biologics
  • Epistem Holdings PLC
  • EuBiologics Co., Ltd.
  • GE Healthcare
  • GVK Biosciences Private Limited
  • Hitachi Chemical Advanced Therapeutics Solutions, LLC
  • Lonza Group Ltd.
  • MilliporeSigma
  • NAEJA-RGM Pharmaceuticals, Inc.
  • Paragon Bioservices, Inc.
  • Patheon, Inc.
  • Promocell GmbH
  • Samsung BioLogics
  • Sartorius AG
  • Selexis SA
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Cell Line Development Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Cell Line Development Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Cell Line Development Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Equipment (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 4: Equipment (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Reagents & Media (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 6: Reagents & Media (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 7: Accessories & Consumables (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Accessories & Consumables (Product Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 9: Bioproduction (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
  • TABLE 10: Bioproduction (Application) Share Breakdown Review by Region/Country: 2020 VS 2027
  • TABLE 11: Tissue Engineering & Regenerative medicine (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 12: Tissue Engineering & Regenerative medicine (Application) Distribution of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 13: Toxicity Testing (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 14: Toxicity Testing (Application) Global Market Share Distribution by Region/Country for 2020 and 2027
  • TABLE 15: Research (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 16: Research (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 17: Drug Discovery (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 18: Drug Discovery (Application) Market Share Shift across Key Geographies: 2020 VS 2027
  • TABLE 19: Mammalian (Source) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 20: Mammalian (Source) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 21: Non-Mammalian (Source) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 22: Non-Mammalian (Source) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 23: Recombinant (Cell Line) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 24: Recombinant (Cell Line) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 25: Hybridomas (Cell Line) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 26: Hybridomas (Cell Line) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 27: Continuous Cell Line (Cell Line) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
  • TABLE 28: Continuous Cell Line (Cell Line) Market Percentage Share Distribution by Region/Country: 2020 VS 2027
  • TABLE 29: Primary Cell Line (Cell Line) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
  • TABLE 30: Primary Cell Line (Cell Line) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cell Line Development Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 31: United States Cell Line Development Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 32: United States Cell Line Development Market Share Breakdown by Product Type: 2020 VS 2027
    • TABLE 33: United States Cell Line Development Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
    • TABLE 34: Cell Line Development Market Share Breakdown in the United States by Application: 2020 VS 2027
    • TABLE 35: United States Cell Line Development Market Estimates and Projections in US$ Million by Source: 2020 to 2027
    • TABLE 36: United States Cell Line Development Market Share Breakdown by Source: 2020 VS 2027
    • TABLE 37: United States Cell Line Development Market Estimates and Projections in US$ Million by Cell Line: 2020 to 2027
    • TABLE 38: United States Cell Line Development Market Share Breakdown by Cell Line: 2020 VS 2027
  • CANADA
    • TABLE 39: Canadian Cell Line Development Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 40: Cell Line Development Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2020 and 2027
    • TABLE 41: Canadian Cell Line Development Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 42: Canadian Cell Line Development Market Share Analysis by Application: 2020 VS 2027
    • TABLE 43: Canadian Cell Line Development Market Estimates and Forecasts in US$ Million by Source: 2020 to 2027
    • TABLE 44: Cell Line Development Market in Canada: Percentage Share Breakdown of Sales by Source for 2020 and 2027
    • TABLE 45: Canadian Cell Line Development Market Estimates and Forecasts in US$ Million by Cell Line: 2020 to 2027
    • TABLE 46: Cell Line Development Market in Canada: Percentage Share Breakdown of Sales by Cell Line for 2020 and 2027
  • JAPAN
    • TABLE 47: Japanese Market for Cell Line Development: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 48: Japanese Cell Line Development Market Share Analysis by Product Type: 2020 VS 2027
    • TABLE 49: Japanese Demand Estimates and Forecasts for Cell Line Development in US$ Million by Application: 2020 to 2027
    • TABLE 50: Cell Line Development Market Share Shift in Japan by Application: 2020 VS 2027
    • TABLE 51: Japanese Market for Cell Line Development: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2020-2027
    • TABLE 52: Japanese Cell Line Development Market Share Analysis by Source: 2020 VS 2027
    • TABLE 53: Japanese Market for Cell Line Development: Annual Sales Estimates and Projections in US$ Million by Cell Line for the Period 2020-2027
    • TABLE 54: Japanese Cell Line Development Market Share Analysis by Cell Line: 2020 VS 2027
  • CHINA
    • TABLE 55: Chinese Cell Line Development Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 56: Chinese Cell Line Development Market by Product Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 57: Chinese Demand for Cell Line Development in US$ Million by Application: 2020 to 2027
    • TABLE 58: Chinese Cell Line Development Market Share Breakdown by Application: 2020 VS 2027
    • TABLE 59: Chinese Cell Line Development Market Growth Prospects in US$ Million by Source for the Period 2020-2027
    • TABLE 60: Chinese Cell Line Development Market by Source: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 61: Chinese Cell Line Development Market Growth Prospects in US$ Million by Cell Line for the Period 2020-2027
    • TABLE 62: Chinese Cell Line Development Market by Cell Line: Percentage Breakdown of Sales for 2020 and 2027
  • EUROPE
    • Market Facts & Figures
    • European Cell Line Development Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 63: European Cell Line Development Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 64: European Cell Line Development Market Share Shift by Region/Country: 2020 VS 2027
    • TABLE 65: European Cell Line Development Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 66: European Cell Line Development Market Share Breakdown by Product Type: 2020 VS 2027
    • TABLE 67: European Cell Line Development Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 68: European Cell Line Development Market Share Analysis by Application: 2020 VS 2027
    • TABLE 69: European Cell Line Development Market Estimates and Forecasts in US$ Million by Source: 2020-2027
    • TABLE 70: European Cell Line Development Market Share Breakdown by Source: 2020 VS 2027
    • TABLE 71: European Cell Line Development Market Estimates and Forecasts in US$ Million by Cell Line: 2020-2027
    • TABLE 72: European Cell Line Development Market Share Breakdown by Cell Line: 2020 VS 2027
  • FRANCE
    • TABLE 73: Cell Line Development Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 74: French Cell Line Development Market Share Analysis by Product Type: 2020 VS 2027
    • TABLE 75: Cell Line Development Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
    • TABLE 76: French Cell Line Development Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
    • TABLE 77: Cell Line Development Market in France by Source: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 78: French Cell Line Development Market Share Analysis by Source: 2020 VS 2027
    • TABLE 79: Cell Line Development Market in France by Cell Line: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 80: French Cell Line Development Market Share Analysis by Cell Line: 2020 VS 2027
  • GERMANY
    • TABLE 81: Cell Line Development Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 82: German Cell Line Development Market Share Breakdown by Product Type: 2020 VS 2027
    • TABLE 83: Cell Line Development Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
    • TABLE 84: Cell Line Development Market Share Distribution in Germany by Application: 2020 VS 2027
    • TABLE 85: Cell Line Development Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2020-2027
    • TABLE 86: German Cell Line Development Market Share Breakdown by Source: 2020 VS 2027
    • TABLE 87: Cell Line Development Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cell Line for the Period 2020-2027
    • TABLE 88: German Cell Line Development Market Share Breakdown by Cell Line: 2020 VS 2027
  • ITALY
    • TABLE 89: Italian Cell Line Development Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 90: Italian Cell Line Development Market by Product Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 91: Italian Demand for Cell Line Development in US$ Million by Application: 2020 to 2027
    • TABLE 92: Italian Cell Line Development Market Share Breakdown by Application: 2020 VS 2027
    • TABLE 93: Italian Cell Line Development Market Growth Prospects in US$ Million by Source for the Period 2020-2027
    • TABLE 94: Italian Cell Line Development Market by Source: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 95: Italian Cell Line Development Market Growth Prospects in US$ Million by Cell Line for the Period 2020-2027
    • TABLE 96: Italian Cell Line Development Market by Cell Line: Percentage Breakdown of Sales for 2020 and 2027
  • UNITED KINGDOM
    • TABLE 97: United Kingdom Market for Cell Line Development: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 98: United Kingdom Cell Line Development Market Share Analysis by Product Type: 2020 VS 2027
    • TABLE 99: United Kingdom Demand Estimates and Forecasts for Cell Line Development in US$ Million by Application: 2020 to 2027
    • TABLE 100: Cell Line Development Market Share Shift in the United Kingdom by Application: 2020 VS 2027
    • TABLE 101: United Kingdom Market for Cell Line Development: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2020-2027
    • TABLE 102: United Kingdom Cell Line Development Market Share Analysis by Source: 2020 VS 2027
    • TABLE 103: United Kingdom Market for Cell Line Development: Annual Sales Estimates and Projections in US$ Million by Cell Line for the Period 2020-2027
    • TABLE 104: United Kingdom Cell Line Development Market Share Analysis by Cell Line: 2020 VS 2027
  • REST OF EUROPE
    • TABLE 105: Rest of Europe Cell Line Development Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 106: Rest of Europe Cell Line Development Market Share Breakdown by Product Type: 2020 VS 2027
    • TABLE 107: Rest of Europe Cell Line Development Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 108: Rest of Europe Cell Line Development Market Share Analysis by Application: 2020 VS 2027
    • TABLE 109: Rest of Europe Cell Line Development Market Estimates and Forecasts in US$ Million by Source: 2020-2027
    • TABLE 110: Rest of Europe Cell Line Development Market Share Breakdown by Source: 2020 VS 2027
    • TABLE 111: Rest of Europe Cell Line Development Market Estimates and Forecasts in US$ Million by Cell Line: 2020-2027
    • TABLE 112: Rest of Europe Cell Line Development Market Share Breakdown by Cell Line: 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 113: Cell Line Development Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 114: Asia-Pacific Cell Line Development Market Share Analysis by Product Type: 2020 VS 2027
    • TABLE 115: Cell Line Development Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
    • TABLE 116: Asia-Pacific Cell Line Development Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
    • TABLE 117: Cell Line Development Market in Asia-Pacific by Source: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 118: Asia-Pacific Cell Line Development Market Share Analysis by Source: 2020 VS 2027
    • TABLE 119: Cell Line Development Market in Asia-Pacific by Cell Line: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 120: Asia-Pacific Cell Line Development Market Share Analysis by Cell Line: 2020 VS 2027
  • REST OF WORLD
    • TABLE 121: Rest of World Cell Line Development Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 122: Cell Line Development Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2020 and 2027
    • TABLE 123: Rest of World Cell Line Development Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 124: Rest of World Cell Line Development Market Share Analysis by Application: 2020 VS 2027
    • TABLE 125: Rest of World Cell Line Development Market Estimates and Forecasts in US$ Million by Source: 2020 to 2027
    • TABLE 126: Cell Line Development Market in Rest of World: Percentage Share Breakdown of Sales by Source for 2020 and 2027
    • TABLE 127: Rest of World Cell Line Development Market Estimates and Forecasts in US$ Million by Cell Line: 2020 to 2027
    • TABLE 128: Cell Line Development Market in Rest of World: Percentage Share Breakdown of Sales by Cell Line for 2020 and 2027

IV. COMPETITION

  • Total Companies Profiled: 44